Altimmune Inc’s recent filing unveils that its Director Drutz David unloaded Company’s shares for reported $0.11 million on Aug 19 ’24. In the deal valued at $6.90 per share,16,011 shares were sold. As a result of this transaction, Drutz David now holds 41,958 shares worth roughly $0.35 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
UBS initiated its Altimmune Inc [ALT] rating to a Buy in a research note published on November 12, 2024; the price target was $26. A number of analysts have revised their coverage, including Guggenheim’s analysts, who decreased its forecast for the stock in late April from “a Buy” to “a Neutral”. Goldman began covering ALT with “Neutral” recommendation on January 24, 2024. Goldman revised its rating on March 22, 2023. It rated ALT as “a Neutral” which previously was an “a Buy”.
Price Performance Review of ALT
On Tuesday, Altimmune Inc [NASDAQ:ALT] saw its stock fall -6.67% to $8.40. Over the last five days, the stock has lost -6.77%. Altimmune Inc shares have fallen nearly -25.33% since the year began. Nevertheless, the stocks have risen 9.52% over the past one year. While a 52-week high of $14.84 was reached on 02/28/24, a 52-week low of $5.28 was recorded on 08/05/24. SMA at 50 days reached $7.76, while 200 days put it at $7.47.
Levels Of Support And Resistance For ALT Stock
The 24-hour chart illustrates a support level at 8.19, which if violated will result in even more drops to 7.97. On the upside, there is a resistance level at 8.75. A further resistance level may holdings at 9.10. The Relative Strength Index (RSI) on the 14-day chart is 48.91, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 93.58%. Stochastics %K at 21.89% indicates the stock is a holding.
How much short interest is there in Altimmune Inc?
A steep rise in short interest was recorded in Altimmune Inc stocks on 2024-11-29, growing by 0.5 million shares to a total of 23.43 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 22.94 million shares. There was a rise of 2.13%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 01, 2022 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $20 price target.
